Drug Design Development And Therapy

雜志介紹

Drug Design Development And Therapy雜志介紹

《Drug Design Development And Therapy》是一本以English為主的開放獲取國際優秀期刊，中文名稱藥物設計開發和治療，本刊主要出版、報道醫學-CHEMISTRY, MEDICINAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4.7，最新CiteScore 指數為9。

本刊近期中國學者發表的論文主要有：

• Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles

  Author: Zhu, Yuanyuan; Zhang, Wei; Chen, Jing

• Menthone Exerts its Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus by Affecting Cell Membrane Properties and Lipid Profile

  Author: Zhao, Wenming; Yang, Chengwei; Zhang, Ning; Peng, Yuanyuan; Ma, Ying; Gu, Keru; Liu, Xia; Liu, Xiaohui; Liu, Xijian; Liu, Yumin; Li, Songkai; Zhao, Linjing

• Evaluation of Chitosan-Oleuropein Nanoparticles on the Durability of Dentin Bonding

  Author: Zhao, Shuya; Zhang, Yunyang; Chen, Yun; Xing, Xianghui; Wang, Yu; Wu, Guofeng

• Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites

  Author: Zhao, Ning; Ma, Yan; Liang, Xiaoxue; Zhang, Yu; Hong, Dacheng; Wang, Ying; Bai, Dong

英文介紹

Drug Design Development And Therapy雜志英文介紹

Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.

The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.

Specific topics covered by the journal include:

Drug target identification and validation

Phenotypic screening and target deconvolution

Biochemical analyses of drug targets and their pathways

New methods or relevant applications in molecular/drug design and computer-aided drug discovery*

Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)

Structural or molecular biological studies elucidating molecular recognition processes

Fragment-based drug discovery

Pharmaceutical/red biotechnology

Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**

Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development

Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)

Preclinical development studies

Translational animal models

Mechanisms of action and signalling pathways

Toxicology

Gene therapy, cell therapy and immunotherapy

Personalized medicine and pharmacogenomics

Clinical drug evaluation

Patient safety and sustained use of medicines.